Format

Send to

Choose Destination
Oncotarget. 2017 Aug 2;8(41):71317-71324. doi: 10.18632/oncotarget.19813. eCollection 2017 Sep 19.

Role of PLZF as a tumor suppressor in prostate cancer.

Author information

1
Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway.
2
Department of Biosciences, University of Oslo, Oslo, Norway.

Abstract

The promyelocytic leukemia zinc finger (PLZF), also known as ZBTB16 (Zinc Finger And BTB Domain Containing 16), is a transcription factor involved in the regulation of diverse biological processes, including cell proliferation, differentiation, organ development, stem cell maintenance and innate immune cell development. A number of recent studies have now implicated PLZF in cancer progression as a tumor suppressor. However, in certain cancer types, PLZF may function as an oncoprotein. Here, we summarize our current knowledge on the role of PLZF in various cancer types, in particular prostate cancer, including its deregulation, genomic alterations and potential functions in prostate cancer progression.

KEYWORDS:

androgens; promyelocytic leukemia zinc finger; prostate cancer; tumor suppressor

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center